Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Asker Healthcare Group AB ( (SE:ASKER) ) is now available.
Asker Healthcare Group has agreed to acquire 100% of German Healthcare GmbH and Medicalprodukte Vertrieb Flensburg GmbH, two interlinked German homecare-focused medical supplies businesses specialising in incontinence and urology products. The target companies, which also supply clinics and pharmacies and generated around SEK 300 million in revenue with 140 employees in the past financial year, bring both global-branded items and attractive private-label ranges that Asker plans to leverage across its European network; subject to regulatory approval, the deal is expected to close in the first quarter of 2026 and to boost the group’s EBITA margin, strengthening Asker’s market position in the German homecare segment and broadening its product offering for stakeholders across Europe.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK107.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare group that partners with caregivers and patients by providing medical products and solutions. The company builds and acquires leading local businesses to support healthcare systems in improving patient outcomes, reducing total cost of care and promoting a fair, sustainable value chain, and currently operates with more than 4,500 employees in 19 countries, generating revenues of about SEK 16 billion.
Average Trading Volume: 487,661
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK31.46B
For detailed information about ASKER stock, go to TipRanks’ Stock Analysis page.